Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
04:03:45 EDT Tue 07 May 2024
Enter Symbol
or Name
USA
CA



V:NRX - NurExone Biologic Inc. - http://www.nurexone.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NRX - V  2.00.58·0.655.00.61+0.023.42.8250.59  0.62  0.591.19  0.185May 06Apr 2515 min RT 2¢
TSX-V - V2.00.58·0.655.00.61+0.023.41.5120.59  0.61  0.591.19  0.185May 0615 min
CX2 - H 0.62+0.035.11.0120.62  0.62  0.62May 0615 min
CXD - D 0.590.301    Mar 0515 min

Recent Trades - All 5 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-25 12:45C:NRX0.63News ReleaseNurexone Biologic begins trading on OTCQB
2024-04-02 13:17C:NRX0.78News ReleaseNurexone spends $1.54-million (U.S.) on R&D in 2023
2024-04-02 08:53C:NRX0.78SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-04-02 08:18C:NRX0.78SEDAR MD & ASEDAR MD & A
2024-03-27 17:18C:NRX0.76News ReleaseNurexone receives $3.95-million from warrant exercise
2024-03-22 17:17C:NRX0.65News ReleaseNurexone signs deal with Vivox to test Exopten
2024-03-15 16:12C:NRX0.74News ReleaseNurexone shares to list on OTCQB Venture Market
2024-03-08 16:11C:NRX0.82News ReleaseNurexone finalizes lease for Israeli R&D facility
2024-02-20 16:27C:NRX1.09News ReleaseNurexone expands IP portfolio with ExoTherapy platform
2024-02-14 16:34C:NRX0.48News ReleaseNurexone to try to license ExoTherapy
2024-02-02 16:14C:NRX0.305News ReleaseNurexone starts European regulatory process for ExoPTEN
2024-01-17 13:20C:NRX0.265News ReleaseNurexone begins spinal cord research with Inteligex
2024-01-16 18:58C:NRX0.265Private PlacementNurexone Biologic 7,091,993-share private placement
2024-01-05 09:37C:NRX0.295News ReleaseNurexone closes $1.98-million private placement
2023-11-29 14:25C:NRX0.31News ReleaseNurexone Biologic develops 2 RNA sequences
2023-11-24 09:51C:NRX0.31News ReleaseNurexone spends $400,000 (U.S.) on R&D in Q3 2023
2023-11-24 08:08C:NRX0.31SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-24 08:06C:NRX0.31SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-10-30 09:33C:NRX0.31News ReleaseNurexone receives orphan drug designation for ExoPTEN
2023-10-19 13:32C:NRX0.295News ReleaseNurexone adds Dagi to scientific advisory board